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Introduction
　Nonalcoholic fatty liver disease (NAFLD) is considered 
one of the phenotypes of metabolic syndrome, or an addi-
tional feature of metabolic syndrome.1,2  Visceral fat accu-
mulation has been reported to be a more important risk fac-
tor for the development of metabolic syndrome than 
subcutaneous fat,3  and therefore, hepatic fat infiltration in 
NAFLD is correlated with visceral fat accumulation.2,4,5  In 
fact, Koda et al. reported that abdominal subcutaneous fat 
thickness was not different among hepatic steatosis scores, 
as evaluated semi-quantitatively by ultrasonography, and 
visceral fat was the most important factor for the develop-
ment of hepatic steatosis.6  However, Koda et al. also dem-
onstrated that the change in abdominal subcutaneous fat 
thickness was weakly correlated with changes in hepatic fat 
deposits.6  Furthermore, Choudhary et al. reported that sub-
cutaneous adipose tissue (SAT) volume defined as fat super-
ficial to the abdominal and back muscles was correlated with 
hepatic steatosis and severity of liver disease, whereas vis-
ceral adipose tissue (VAT) volume was not correlated with 
severity of liver disease in Indian patients with NAFLD.7 
Thus, abdominal SAT may be an important adipose tissue 
compartment that should not be overlooked.
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　The aim of the present study was to elucidate the correla-
tion between abdominal VAT or SAT volume and severity of 
hepatic fat accumulation by computed tomographic (CT), 
biochemical, or histopathological evaluation in Sprague-
Dawley (SD) rats fed a normal or high-fat diet.
Materials and Methods
Animals and experimental design
　Five-week-old male SD rats (n=19) were purchased from 
Japan SLC Inc. (Hamamatsu, Japan). Rats were housed in 
individual cages that were kept in a room maintained at 22-
24℃ with 50-60% relative humidity and a 12-hour light/
dark cycle. All rats were acclimatized for 7 days, during 
which they had access to standard diet containing 10% fat 
(5.5% soybean oil and 4.4% lard, kcal) (D12450B; Research 
Diets Inc., New Brunswick, NJ, USA) and water ad libitum. 
After acclimation, rats were randomly divided into 3 groups: 
a control group (C group, n=6) fed a standard diet (D12450B; 
Research Diets); a middle-high fat diet group (M group, 
n=6) fed a diet containing 45% fat (5.5% soybean oil and 
39.4% lard, kcal) (D12451; Research Diets); and a high-fat 
diet group (H group, n=7) fed a diet containing 60% fat 
(5.5% soybean oil and 54.4% lard, kcal) (D12492; Research 
Diets). The proximate compositions of the diets fed to rats 
are shown in Table 1. Daily energy intake and body weights 
were monitored during the study. 







gram kcal gram kcal gram kcal
Casein 200 800 200 800 200 800
L-cystine 3 12 3 12 3 12
Cornstarch 315 1260 72.8 291 0 0
Maltodextrin 35 140 100 400 125 500
Sucrose 350 1400 172.8 691 68.8 272
Cellulose 50 0 50 0 50 0
Soybean oil 25 225 25 225 25 225
Lard 20 180 177.5 1598 245 2205
Mineral mix 10 0 10 0 10 0
Dicalcium phosphate 13 0 13 0 13 0
Calcium carbonate 5.5 0 5.5 0 5.5 0
Potassium citrate, 1H2O 16.5 0 16.5 0 16.5 0
Vitamin mix 10 40 10 40 10 40
Choline bitartrate 2 0 2 0 2 0
Yellow, red, or blue dye 0.05 0 0.05 0 0.05 0
Total 1055.05 4057 858.15 4057 773.85 4057
Protein (%) 19 20 24 20 26 20
Carbohydrate (%) 67 70 41 35 26 20
Fat (%) 4 10 24 45 35 60
Total 100 100 100
Energy (kcal/gram) 3.8 4.7 5.2
*This number was provided by Research Diets Inc. (New Brunswick, NJ, USA).
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　At 22 weeks of age, rats underwent CT measurement, and 
were sacrificed under anesthesia (pentobarbital sodium) after 
12-hour fasting. Blood samples were taken from the inferior 
vena cava or the heart for analysis of biochemical parameters. 
Serum samples were kept at −20℃ until analysis. Livers 
were removed, washed in cold saline, and weighed. Liver 
portions (approximately 5g) were fixed in 10% neutral 
buffered formalin for histopathological examination. Other 
liver portions (0.5g) were immediately frozen in liquid 
nitrogen and were stored at −80℃ for hepatic total 
cholesterol (TC) and triglyceride (TG) measurement. 
　All procedures were performed in accordance with the 
Guide for the Care and Use of Laboratory Animals (eighth 
edition, National Research Council of the National 
Academies), and were approved by the Animal Usage 
Committee of the University of Nagasaki, Japan.
Computed tomography (CT) imaging
　Computed tomographic (CT) images were obtained using 
an X-ray CT system (Latheta LCT-100 Lite; Hitachi Aloka 
Medical Ltd., Tokyo, Japan) for imaging experimental 
animals according to the manufacturerʼs protocol. Rats at 22 
weeks of age were anesthetized with isoflurane before CT 
scanning, and were then mounted on a holder and placed in 
the X-ray CT system. In the present study, CT imaging from 
the upper end of the diaphragm to the root of the tail was 
evaluated. Quantitative assessment of the lesion area was 
performed with Latheta software version 3.00 (Hitachi Aloka 
Medical). Abdominal weight of the muscle, VAT, and SAT 
were calculated from cumulative area measurement and 
mean CT values (Hounsfield unit, HU) of each CT slice. 
Abdominal VAT weight/body weight ratio, abdominal SAT 
weight/body weight ratio, and abdominal VAT weight/SAT 
weight ratio were also calculated. Fat percentage of the liver 
(%) was calculated as follows: (mean CT value of muscle – 
mean CT value of liver) / (mean CT value of muscle – mean 
CT value of fat) x 100, in accordance with the manufacturerʼs 
information, which was modified from a previously reported 
formula.8 
Serum biochemical analysis
　Serum TC and TG levels were measured using the 
cholesterol oxidase DAOS method (Cholesterol E test Wako, 
Wako Pure Chemical Industries Ltd., Osaka, Japan) and the 
GPO DAOS glycerol method (Triglyceride E test Wako, 
Wako Pure Chemical Industries), respectively. Serum high-
density lipoprotein cholesterol (HDL-C) and free fatty acid 
(FFA) levels were measured using the phosphotungstic acid 
magnesium chloride precipitation method (HDL-cholesterol 
E test Wako; Wako Pure Chemical Industries), and the ACS 
ACOD method (NEFA C test Wako; Wako Pure Chemical 
Industries), respectively. Serum glucose levels were 
measured using the mutarotase and glucose oxidase method 
(Glucose C II test Wako; Wako Pure Chemical Industries). 
Serum insulin levels were measured with a rat insulin 
enzyme-linked immunosorbent assay (ELISA) kit (Morinaga 
Institute of Biological Science Inc., Yokohama, Japan). 
Serum adiponectin levels were measured with a mouse/rat 
ELISA kit (Otsuka Pharmaceuticals Co., Ltd., Tokyo, Japan). 
Serum leptin levels were measured with a Leptin ELISA kit 
(Morinaga Institute of Biological Science). Because the units 
of measurement in the present study were not same as in the 
previously reported homeostasis model assessment-insulin 
resistance (HOMA-IR) and adipose tissue insulin resistance 
(Adipo-IR),9,10  “HOMA-IR index” was calculated as the 
product of fasting serum glucose (mg/dL) × fasting serum 
insulin (ng/mL) concentration, while “Adipo-IR index” was 
calculated as the product of fasting serum FFA (mEq/L) × 
fasting serum insulin (ng/mL) concentration.
Hepatic TC and TG concentrations
　Lipids in the livers were extracted from frozen livers 
(0.5g) with the Bligh-Dyer extraction method,11 and extracted 
TC and TG were measured using individual assay kits 
(Cholesterol E test Wako and triglyceride E test Wako, 
respectively) as described above. 
Histopathological examination
　After fixation in neutral-buffered formalin, liver tissues 
were embedded in paraffin, sectioned, and processed for 
hematoxylin-eosin (HE) staining for histopathological 
examination. All histopathological examinations were 
performed by a pathologist (K.T.) who was blinded to the 
experimental and serological data. Histopathological findings 
were scored using the NASH Clinical Research Network 
Scoring System based on four semi-quantitative factors, as 
described previously:12  steatosis (0-3); lobular inflammation 
(0-3); hepatocyte ballooning (0-2); and fibrosis (0-4). In the 
present study, scores for steatosis, lobular inflammation, and 
hepatocyte ballooning were further classified as follows: 
score 0.5, the feature was between scores 0 and 1; score 1.5, 
between scores 1 and 2; and score 2.5, between scores 2 and 
3.NAFLD activity score (NAS) was defined as the unweighted 
sum of the scores for steatosis, lobular inflammation, and 
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hepatocyte ballooning; thus, scores ranged from 0 to 8. A 
NAS of 0 to 2 was not considered to be diagnostic of 
steatohepatitis, and scores of 5 or greater were considered to 
be diagnostic of steatohepatitis.12
Statistical analysis
　All values were expressed as mean ± standard error (SE). 
Differences between the three groups were tested for 
statistical significance using one-way analysis of variance 
(ANOVA), followed by Bonferroni multiple comparison 
test, chi-squared test, or Fisherʼs exact probability test. 
Correlations between two variables were determined by 
Spearmanʼs rank correlation coefficient. All analyses were 
performed using IBM SPSS statistics software program, 
version 21 (IBM Co., Somers, NY, USA) on a Windows 
computer. A p value of less than 0.05 was considered to be 
statistically significant.
Results
Food intake, body weight, and liver weight/body weight ratio
　Cumulative energy intake during the 16-week study period 
was not significantly different among the groups, but body 
weight at 22 weeks of age and weight gain during the 16-
week study period was significantly larger in the M group 
than that in the C group (p=0.036 and 0.027, respectively). 
Liver weight/body weight ratio was significantly larger in 
the C group than in the H group (p=0.041, Table 2). 
Computed tomography (CT) parameters
　Representative CT imaging for quantitative assessment of 
the lesion area is shown in Figure 1. Abdominal VAT weight/
body weight ratio and SAT weight/body weight ratio were 
larger in the M group and H group than those in the C group 
(p<0.001 and 0.003, respectively). Abdominal VAT weight/
SAT weight ratios were not significantly different among the 
groups. Body weight at 22 weeks of age and weight gain 
during the 16-week study period were not correlated with 
abdominal VAT weight/SAT weight ratios (p=0.424 and 
0.258, respectively). Mean CT value of the liver was highest 
in the C group (74.4 ± 2.5 HU), followed by the M group 
(56.4 ± 3.8 HU) and the H group (42.5 ± 3.8 HU, p<0.001). 
The calculated fat percentage of the liver was lowest in the 
C group, followed by the M group and the H group (p<0.001, 
Table 2).
Serum biochemical parameters
　Serum TC and HDL-C levels were significantly higher in 
the M group than in the H group (p=0.017 and 0.014, 
respectively). Serum TG and FFA levels were significantly 
higher in the C group than in the H group (p=0.001 and 
0.026, respectively). There were no significant differences in 
serum levels of glucose, insulin, adiponectin, leptin, HOMA-
IR index, and Adipo-IR index among the groups (Table 2).
Fig.1 
a b 
Figure 1.   Representative CT imaging for quantitative assessment of lesion area. (a): Raw gray scale scan 
slice. (b): Selected areas of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue 
(SAT) are indicated in pink and yellow, respectively. A, anterior; P, posterior; R, right; L, left.
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Hepatic lipid concentrations
　Hepatic TC concentrations were highest in the H group and 
lowest in the C group, but there were no significant differences. 
Hepatic TG concentrations were significantly higher in the 
H group than those in the C group (p=0.017, Table 2).
Histopathological observation
　There were no significant differences in score/grade of 
hepatic steatosis, lobular inflammation, hepatocyte ballooning, 
or NAS among the three groups. NAS of 5 points or greater, 
or hepatic fibrosis was not observed in any rats (Table 2).
Table 2. Cumulative energy intake, body weight, liver weight/body weight ratio, CT parameters, serum biochemical pa-








Cumulative energy intake (kcal) 9822 ± 272 11207 ± 272 10976 ± 216
Final body weight (g) 547 ± 13a 598 ± 10b 579 ± 14ab
Weight gain (g) 382 ± 14c 437 ± 10d 416 ± 13cd
Liver weight/BW ratio (%) 2.8 ± 0.1e 2.7 ± 0.1ef 2.5 ± 0.1f
CT parameters
　Abdominal VAT weight / BW ratio (%) 7.8 ± 0.3g 11.7 ± 0.5h 11.6 ± 0.4h
　Abdominal SAT weight / BW ratio (%) 3.4 ± 0.3i 5.9 ± 0.4j 5.9 ± 0.5j
　Abdominal VAT weight / SAT weight ratio (%) 234.1 ± 14.0 201.0 ± 13.6 207.1 ± 16.3
　Fat percentage of liver (%) 2.4 ± 0.7k 8.1 ± 1.3l 12.8 ± 1.3m
Serum biochemical parameters
　Serum TC (mg/dL) 110 ± 4no 119 ± 13n 79 ± 8o
　Serum TG (mg/dL) 195 ± 17p 144 ± 15pq 108 ± 7q
　Serum HDL-C (mg/dL) 59 ± 1rs 65 ± 6r 41 ± 3s
　Serum FFA (mEq/L) 0.64 ± 0.06t 0.55 ± 0.03tu 0.43 ± 0.05u
　Serum glucose (mg/dL) 190 ± 10 170 ± 10 183 ± 7
　Serum insulin (ng/mL) 4.7 ± 0.2 5.1 ± 1.0 5.3 ± 0.6
　Adiponectin ( μg/mL) 3.5 ± 0.2 5.0 ± 0.5 4.3 ± 0.8
　Leptin (ng/mL) 14.5 ± 1.2 20.7 ± 1.4 19.4 ± 1.8
　HOMA-IR index (glucose x insulin) 2.22 ± 0.16 2.17 ± 0.44 2.42 ± 0.30
　Adipo-IR index (FFA x insulin) 2.97 ± 0.22  2.85 ± 0.70 2.26 ± 0.31
Hepatic lipid contents
　Hepatic TC (mg/g liver) 3.9 ± 0.5 6.3 ± 1.1 7.1 ± 0.9
　Hepatic TG (mg/g liver) 31.8 ± 7.0v 58.6 ± 12.3vw 74.3 ± 8.6w
Histopathological findings (score)
　Steatosis (0/0.5/1/1.5/2) 3/1/2/0/0 1/4/1/0/0 1/3/2/1/0
　Lobular inflammation (0/1/2) 4/2/0 3/3/0 2/4/1
　Hepatocyte ballooning (0/0.5/1) 6/0/0  3/2/1 2/4/1
　NAS (0-2/2.5-4.5/5-8) 6/0/0  4/2/0 5/2/0
　Fibrosis (0/1-4) 6/0  6/0 7/0
Values are means ± SE. Different superscript letters within the same parameter indicate significant differences at p<0.05.
CT, computed tomography; BW, body weight; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; TC, total cholesterol; 
TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; FFA, free fatty acid; NAS, NAFLD activity score. 
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Correlations between adipose and liver tissue variables
　Correlations between adipose and liver tissue variables by 
anthropometric, CT, biochemical, or histopathological 
evaluation are summarized in Table 3. Abdominal SAT 
weight/body weight ratio was correlated positively and 
strongly with abdominal VAT weight/body weight ratio 
(r=0.801, p<0.001). Abdominal SAT weight/body weight 
ratio and abdominal VAT weight/SAT weight ratios revealed 
a strong negative correlation (r=-0.765, p<0.001). 
　Hepatic fat accumulation indices, i.e., fat percentage of 
liver on CT evaluation, hepatic TG content, and hepatic 
steatosis score by histopathological evaluation showed 
positive correlations with one another (Figure 2). Of these 
hepatic fat accumulation indices, fat percentage of the liver 
by CT evaluation was positively correlated with both 
abdominal VAT weight/body weight ratio and SAT weight/
body weight ratio. Hepatic TG content was also positively 
correlated with both abdominal VAT weight/body weight 
ratio and SAT weight/body weight ratio. Moreover, hepatic 
TG content was negatively correlated with abdominal VAT 
weight/SAT weight ratios. On the other hand, hepatic steatosis 
score by histopathological evaluation was not correlated 
with any of abdominal VAT or SAT weight/body weight and 
VAT weight/SAT weight ratios (Figure 3).
Table 3. Correlations between adipose and liver tissue variables by anthropometric, CT, biochemical, or histopathological evaluation.




SAT/BW 0.101 0.801 1.000
 (0.682) (<0.001)
VAT/SAT -0.366 -0.342 -0.765 1.000
 (0.123) (0.152) (<0.001)
L-%fat -0.010 0.663 0.623 -0.420 1.000
(0.969) (0.002) (0.004)  (0.074)
H-TC 0.174 0.400 0.475 -0.454 0.665 1.000
(0.477) (0.090)  (0.040)  (0.051)  (0.002) 
H-TG 0.181 0.478 0.605 -0.587 0.749 0.900 1.000
(0.459) (0.038) (0.006)  (0.008) (<0.001) (<0.001)
HS 0.267 0.233 0.216 -0.336 0.546 0.743 0.771 1.000
(0.270) (0.336) (0.375) (0.159) (0.016)  (<0.001)  (<0.001)
LI 0.222 0.351 0.321 -0.284 0.470 0.614 0.665 0.580 1.000
（0.360） （0.141） （0.180） （0.238） （0.042） （0.005） （0.002） （0.009）
HB 0.259 0.533 0.390 -0.239 0.709 0.548 0.547 0.495 0.434 1.000
（0.284） （0.019） （0.099） （0.325） （0.001） （0.015） （0.015） （0.031） （0.063）
NAS  0.353 0.395 0.360 -0.369 0.661 0.769  0.802 0.848 0.833  0.757 1.000
(0.138) (0.095)  (0.130) (0.120)  (0.002) (<0.001) (<0.001) (<0.001)  (<0.001) (<0.001)
Data are shown in terms of  r values (p values).
LW/BW, Liver weight/body weight (BW) ratio; VAT/BW, Abdominal visceral adipose tissue (VAT) weight/BW ratio by computed tomography (CT) 
evaluation; SAT/BW, Abdominal subcutaneous adipose tissue (SAT) weight/BW ratio by CT evaluation; VAT/SAT; Abdominal VAT weight/SAT weight 
ratio by CT evaluation; L-%fat, Fat percentage of liver by CT evaluation; H-TC, Hepatic total cholesterol; H-TG, Hepatic triglyceride; HS, Hepatic ste-
atosis by histopathological evaluation; LI; Lobular inflammation by histopathological evaluation; HB, Hepatocyte ballooning by histopathological evalu-
ation; NAS, NAFLD activity score
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Figure 3. Correlations between VAT/BW, SAT/BW, or VAT/SAT and fat percentage of the 
liver by CT evaluation (a-c), hepatic TG content (d-f), or hepatic steatosis score by histo-
pathological evaluation (g-i). VAT/BW, abdominal visceral adipose tissue (VAT) weight/body 
weight (BW) ratio by computed tomography (CT) evaluation; SAT/BW, abdominal subcu-
taneous adipose tissue (SAT) weight/BW ratio by CT evaluation; VAT/SAT, abdominal VAT 
weight/SAT weight ratio by CT evaluation.
Figure 2. Correlations between hepatic fatty accumulation indices. Fat percentage 
of the liver by CT evaluation and hepatic TG content (a), fat percentage of the liver 
by CT evaluation and hepatic steatosis score by histopathological evaluation (b), and 
hepatic TG content and hepatic steatosis score by histopathological evaluation (c) 
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　In order to elucidate the correlation between abdominal 
VAT or SAT volume and severity of hepatic fat accumulation, 
SD rats were fed a normal diet or high-fat diet (containing 
45% or 60% fat) for 16 weeks in the present study. In SD rats 
fed a high-fat diet for a relatively short period (3 to 12 
weeks), hepatic fat accumulation can be observed before a 
significant increase in peripheral fat deposition.13 In the 
present study, abdominal VAT and SAT weight/body weight 
ratios were significantly larger at 22 weeks of age in groups 
fed a high-fat diet (M and H group) than those fed the normal 
diet (C group). Hepatic fat accumulation as evaluated by CT 
measurement of fat percentage of the liver and hepatic TG 
concentration were also significantly larger in high-fat diet 
groups (M or H group) than those in the normal diet group 
(C group). Because final body weight and weight gain during 
the 16-week study period were not correlated with abdominal 
VAT weight/SAT weight ratios, it is unlikely that SAT 
deposition occurred prior to VAT deposition.  As abdominal 
VAT weight/body weight ratio revealed a strong positive 
correlation with abdominal SAT weight/body weight ratio, 
there were no correlations in abdominal VAT weight/SAT 
weight ratios among the three groups. 
　Visceral and subcutaneous adipose tissues have different 
structures and functions. Visceral adipose tissue is more 
cellular, vascular, innervated, and contains a large number of 
inflammatory and immune cells, lesser preadipocyte 
differentiating capacity and a greater percentage of large 
adipocytes than SAT. Moreover, VAT is also metabolically 
more active in producing adipocytokines such as leptin, 
tumor necrosis factor-alpha (TNF-alpha), interleukin 6, 
angiotensinogen, plasminogen activator inhibitors-1 (PAI-
1), and adiponectin. These adipocytokines flow directly into 
the liver via the portal vein.2,3,7,14  Therefore, visceral fat 
accumulation may be a more important risk factor for the 
development of metabolic syndrome or hepatic fat accumulation 
than subcutaneous fat.2-5  In the present study, hepatic fat 
accumulation indices such as fat percentage of the liver by 
CT evaluation and hepatic TG content were positively 
correlated with abdominal VAT weight/body weight ratio, as 
reported previously.6
　In the present study, abdominal SAT weight/body weight 
ratio also revealed positive correlations with hepatic fat 
accumulation indices. It was particularly noteworthy that 
hepatic TG content was negatively correlated with abdominal 
VAT weight/SAT weight ratios. This suggests that hepatic 
TG content was correlated more strongly with abdominal 
SAT weight than VAT weight. Subcutaneous fat accumulation 
represents the normal physiological buffer for excess energy 
intake with limited energy expenditure. In humans, about 
80% of all body fat is in the subcutaneous area and visceral 
fat accounts for up to 10-20% of total fat in men and 5-8% in 
women.14  Therefore, it is possible that SAT volume actually 
contributes to more absolute risk for metabolic syndrome or 
hepatic fat accumulation than VAT volume because SAT 
volume is greater than VAT volume.3
　Hepatic fat accumulation is reported to be associated with 
hepatic insulin resistance,15 although hepatic fat accumulation 
was not correlated with insulin resistance in the present 
study (Table 2). Adipocytes from VAT were reported to be 
more insulin-resistant than those from SAT.14  However, 
Garg reported that SAT was more strongly associated with 
insulin resistance than VAT in human studies.16  Maruyama 
et al. also reported that changes in fasting insulin concentration 
were correlated more strongly with changes in SAT volume 
than those in VAT volume in 744 adults.17  In this context, 
Ishikawa et al. reported that SAT regulates systemic insulin 
sensitivity by altering fat storage and the expression of TNF-
alpha by adipocytes in VAT. Therefore, the balance between 
SAT and VAT accumulation may be important in systemic 
insulin resistance in metabolic syndrome.18  Amati et al. also 
reported that VAT and thigh SAT had markedly opposite 
associations with insulin sensitivity; thigh SAT exerted a 
protective influence against peripheral insulin resistance.19 
However, this was not evident in the present study, as “adipo-
IR index” was not statistically different among the C, M and 
H groups (Table 2), and fasting serum insulin and glucose 
were not significantly correlated with abdominal SAT 
weight/body weight ratio or abdominal VAT weight/body 
weight ratio (data not shown).
　In the present study, hepatic fatty accumulation indices 
such as fat percentage of the liver by CT evaluation, hepatic 
TG content, and hepatic steatosis score by histopathological 
evaluation showed positive correlations with one another 
(Figure 2). However, correlations between such hepatic fat 
accumulation indices and abdominal VAT or SAT deposits 
did not show identical results. Measurement of fat percentage 
of the liver by CT is a simple, non-invasive method for 
evaluating all parts of the liver, but this method requires 
expensive equipment and exposure to radiation. Chemical 
measurement of hepatic lipid concentration has the 
advantages of being precise and able to measure TG, as well 
as TC, but this method evaluates only a small part of the 
liver tissue, and therefore runs the risk of “sampling error”. 
Histopathological evaluation of the liver can evaluate both 
steatosis and other features, such as lobular inflammation, 
hepatocyte ballooning, and fibrosis. However, this method 
Discussion
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also evaluates a small part of the liver tissue, and therefore 
runs the risk of “sampling error”. In clinical settings, 
percutaneous liver biopsy has a risk of complications such as 
bleeding, pain, and hypotension.20 In the present study, it 
should therefore be noted that hepatic fat accumulation as 
evaluated by fat percentage of the liver by CT evaluation, 
hepatic TG content, and hepatic steatosis score by 
histopathological evaluation were negatively correlated with 
abdominal VAT weight/SAT weight ratios (r=-0.420, -0.587, 
and -0.336, respectively) (Table 3 and Figure 3), although 
only hepatic TG content showed a significant difference. 
This finding indicates that hepatic fat accumulation is more 
closely correlated with abdominal SAT weight than with 
VAT weight.
　It is known that increased serum TG and decreased serum 
HDL-C levels are associated with severity of NAFLD.21 
However, serum TC levels were significantly lower in the H 
group than those in the M group, and serum TG and FFA 
levels were significantly lower in the H group than those in 
the C group in the present study (Table 2). This may be due 
to the “12-hour fasting” and the subsequent imbalance in TG 
acquisition and removal in the liver of rats fed a high-fat 
diet. Cahova et al. reported that serum TG and FFA in 
hereditary hypertriglyceridemic (HHTg) rats fed a high-fat 
diet and fasted for 24 hours were lower than those in HHTg 
rats fed a high-sucrose diet.22 The authors concluded that 
high-fat diet associated steatosis was characterized by 
downregulated FFA synthesis de novo, increased FFA 
oxidation, and significantly impaired very low density 
lipoprotein (VLDL) output.22
　In conclusion, our results showed that abdominal SAT 
accumulation, rather than abdominal VAT accumulation, is 
positively correlated with hepatic steatosis in SD rats. 
Therefore, physicians, nurses, dieticians, and investigators 
should pay closer attention to SAT status, in addition to VAT. 
Further investigations will be needed in order to clarify the 
precise mechanisms responsible for the effects of SAT and 
VAT on the development of NAFLD.
Conflict of interest
　The authors have no conflicts of interest to declare. 
Acknowledgements
　This study was partly supported by a Grant-in-Aid for 
Scientific Research from the Japanese Ministry of Education, 
Culture, Sports, Science, and Technology to K. Omagari 
(No. 24614011), and by the Project Research Fund of 
University of Nagasaki to S. Kato.
References
 1) Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver dis-
ease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850, 2001
 2) Eguchi Y, Eguchi T, Mizuta T, et al. Visceral fat accumulation and 
insulin resistance are important factors in nonalcoholic fatty liver dis-
ease. J Gastroenterol 41: 462-469, 2006
 3) Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and sub-
cutaneous adipose tissue compartments. Association with metabolic 
risk factors in the Framingham Heart Study. Circulation 166: 39-48, 
2007
 4) Mahmood S, Taketa K, Imai K, et al. Association of fatty liver with 
increased ratio of visceral to subcutaneous adipose tissue in obese 
men. Acta Med Okayama 52: 225-231, 1998
 5) Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepaic/
visceral fat and hepatic insulin resistance in nondiabetic and type 2 
diabetic subjects. Gastroenterology 133: 496-506,2007
 6) Koda M, Kawakami M, Murawaki Y, Senda M. The impact of vis-
ceral fat in nonalcoholic fatty liver disease: cross-sectional and longi-
tudinal studies. J Gastroenterol 42: 897-903, 2007
 7) Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. 
Correlation of adipose tissue with liver histology in Asian Indian pa-
tients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol 11: 
478-486, 2012
 8) Lubura M, Hesse D, Neumann N, Scherneck S, Wiedmer P, Schur-
mann A. Non-invasive quantification of white and brown adipose tis-
sues and liver fat content by computed tomography in mice. PLoS 
ONE 7: e37026, 2012
 9) Gastaldelli A, Harrison SA, Belfort-Aguilar, et al. Importance of 
changes in adipose tissue insulin resistance to histological response 
during thiazolidinedione treatment of patients with nonalcoholic ste-
atohepatitis. Hepatology 50: 1087-1093, 2009
10) Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue 
insulin resistance on metabolic parameters and liver histology in 
obese patients with nonalcoholic fatty liver disease. Hepatology 55: 
1389-1397, 2012
11) Bligh EG, Dyer WJ. A rapid method of total lipid extraction and puri-
fication. Can J Biochem Physiol 37: 911-917, 1959
12) Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a 
histological scoring system for nonalcoholic fatty liver disease. Hepa-
tology 41: 1313-1321, 2005
13) Omagari K, Kato S, Tsuneyama K, et al. Effect of a long-term high-fat 
diet and switching from a high-fat to low-fat, standard diet on hepatic fat 
accumulation in Sprague-Dawley rats. Dig Dis Sci 53: 3206-3212, 2008
14) Ibrahim MM. Subcutaneous and visceral adipose tissue: structural 
and functional differences. Obes Rev 11: 11-18, 2010
15) Samuel VT, Liu Z-X, Qu X, et al. Mechanism of hepatic insulin resis-
tance in non-alcoholic fatty liver disease. J Biol Chem 279: 32345-
32353, 2004
16) Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol 
Metab 89: 4206-4210, 2004
17) Maruyama M, Fukui T, Yoshitaka S, et al. Both visceral fat and sub-
cutaneous fat affect insulin resistance. Ningen Dock (Official Journal 
of Japan Society of Ningen Dock) 24: 146-150, 2009 (in Japanese with 
English abstract).
18) Ishikawa K, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y. 
Subcutaneous fat modulates insulin sensitivity in mice by regulating 
TNF-alpha expression in visceral fat. Horm Metab Res 38: 631-638, 
2006
56 Katsuhisa Omagari et al.: Subcutaneous fat and hepatic steatosis
19) Amati F, Pennant M, Azuma K, et al. Lower thigh subcutaneous and 
higher visceral abdominal adipose tissue content both contribute to 
insulin resistance. Obesity 20: 1115-1117, 2012
20) Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 344: 495-
500, 2001
21) Razavizada M, Jamali R, Arj A, Talari H. Serum parameters predict 
the severity of ultrasonographic findings in non-alcoholic fatty liver 
disease. Hepatobiliary Pancreat Dis Int 11: 513-520, 2012
22) Cahova M, Dankova H, Palenickova E, Papackova Z, Kazdova L. The 
opposite effects of high-sucrose and high-fat diet on fatty acid oxida-
tion and very low density lipoprotein secretion in rat model of meta-
bolic syndrome. J Nutr Metab 2012: 757205: Cited 26 Mar 2014. Avail-
able from URL: http://dx.doi.org/10.1155/2012/757205
